Sano Genetics is accelerating the world's transition to precision medicine by combining genetic testing, recruitment, and long-term engagement in one platform, simplifying operations for precision medicine teams driving breakthroughs for patients.

At Sano, our mission is to accelerate the world's transition to precision medicine.

Sano combines genetic testing, recruitment, and long-term engagement in one platform, accelerating enrollment and simplifying operations for precision medicine teams driving breakthroughs for patients.

UK Research and Innovation

Parkwalk Advisors

University of Cambridge Enterprise

Seedcamp

Daniel Murrell

Jon Folland

Paul Forster

Ramesh Haridas

January Ventures

Paul Wicks

Episode 1

MMC Ventures

Plural Platform

Synetro Group

Margaret Georgiadis

Sano Genetics

George Bowley and I will be venturing to (hopefully) sunny Florida next weekend for SCOPE Summit USA 🌞 ! It's my first time, but I've been prepped that there will be many oranges - thanks George 🍊 😂 

We'd both love to connect with anyone who might want to hear what we do at Sano Genetics 🧬 see you all by the snack stand! 👋

Had such an amazing few days at PMWC - Precision Medicine World Conference in Silicon Valley last week with the Sano Genetics team!

Extremely grateful for the opportunity to meet some of the leading minds in the precision medicine space and demonstrate how Sano Genetics are helping accelerate these precision medicine programs with our integrated platform. 

It was great to attend some of the insightful talks over the course of the three days and see first hand how the precision medicine industry is continuing to flourish! 

Thanks to everyone who stopped by our booth for a chat and if anyone wants to follow-up or didn’t have time to catch-up during the conference, please feel free to reach out anytime! 

Theo Wiley Lindsey Wahlstrom-Edwards

In an era where precision medicine is key, digital tools in clinical genetics are proving indispensable. From enhancing patient-provider relationships to streamlining genetic data analysis, these innovations are setting new benchmarks in healthcare. 🧬 

Discover the potential of digital health technology in our latest blog. 👇 

https://lnkd.in/eFAuTMxC 

#ClinicalTrials #PrecisionMedicine

Cambridge-based Sano Genetics, a software company in the precision medicine research field, has raised $11.4 million in funding, led by Plural with participation from existing investors including MMC Ventures, Episode 1 Ventures and Seedcamp.
Read more here: https://lnkd.in/gDfirEVv

Thank you for sharing Prevail Therapeutics! Looking forward to seeing the impact of this program on the FTD community. 🧠

It was a pleasure discussing this critical topic with you, Daniel Barvin, MBA!

Huge congratulations to Cambridge Angels portfolio company, Sano Genetics on their recent funding! 

https://lnkd.in/eRyfc9ib

Easing myself back into work this week as I recover from my red-eye back from San Francisco 🥵 so I thought I'd share a quick 3 learnings from my experience last week at #PMWC2024 (PMWC - Precision Medicine World Conference).

1. The #precisionmedicine market is trending upwards 📈 : a lot of conversations were not just around trial data and R&D but focused on how we can scale these technologies post-market given the intricacies of manufacturing - in particular, a great session chaired by Morten Sogaard, featuring Pooja Agarwal, David Kirn, MD, Adrian Veres, and Thomas Wechsler, touched on this in great detail.

2. Patient experience is no longer an afterthought 🏥 : There are some incredibly passionate individuals and companies I spoke with who are forward thinking in their approaches towards running clinical trials in this space. We had some brilliant discussions with Jorge Gottheil from GRAIL, Masayuki Kotoku from Akros Pharma Inc., and Fang He from Amgen, centred around tackling this very topic.

3. Whilst the industry is incredibly collaborative, we all love a little competition 🥇 : The buzzwire at Sano Genetics booth was a hit! With an IPad up for grabs we had Eliad Josephson and Stephen Turner battling it out continuously all week, with Eliad coming out on top with a top time of 8.08 seconds. Apologies to our neighbours for all the beeping all week - the volume settings appeared to be fixed 😅

All in all, a great event for us at Sano Genetics. Seemed as if our session on bridging the gaps between recruitment, biomarker testing, and long-term patient engagement touched a nerve. If anyone wants to follow up on how we can support your precision medicine programs, do drop me a DM.

Rory Wilkinson Lindsey Wahlstrom-Edwards Lisa Conroy, MPH

Precision medicine software platform Sano Genetics announced a $11.4 million raise led by Plural.

The only software platform tailored to running precision medicine clinical trials, Sano Genetics leverages AI to manage all aspects, from design to patient recruitment to genetic and other biomarker testing and patient engagement.

Precision medicine is a fast-growing category — today, more than 30 percent of trials are precision-driven and are predicted to reach 80 percent by the end of the decade.

Sano Genetics connects patients across four countries, including the UK, US, Australia and Canada, with pharmaceutical companies and biotech companies conducting clinical trials, making it easier for patients to access precision medical treatment and for companies to bring new, effective drugs to market quickly. 

By providing a digital matchmaking experience for conducting clinical trials, it's quick and seamless for customers to load their new trial into the Sano platform and include the criteria for patients they're looking for. 

Congrats Charlotte Guzzo and team! 🔥

#healthtech #digitalhealth #healthcare #healthcareinnovation #startups #innovation #health #medtech #healthcareresearch #femtech #womenshealth #funding #investment #venturecapital #pharma #publichealth #patients #patientcare #AI #bigdata #lifesciences

Sano Genetics Raises New Funds to Drive Precision Medicine

The $11.4M raised will drive its clinical trials software platform in precision medicine. The company, which was founded by Patrick Short, Charlotte Guzzo, and William Jones who met while studying for their PhDs at the University of Cambridge, has expanded rapidly.

COM:SANOGENETICS

Sano Genetics

Analysis Not Available